![Dave Hanaman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Dave Hanaman
Gründer bei
Curavit Clinical Research Corp.
Profil
Dave Hanaman is the founder of Curavit Clinical Research Corp., which was founded in 2020.
He holds the titles of President & Chief Commercial Officer and Director at Curavit Clinical Research Corp.
Currently, Mr. Hanaman is an Operating Partner at Eden Capital Management LLC.
Mr. Hanaman completed his undergraduate degree at the University of California, Berkeley.
Aktive Positionen von Dave Hanaman
| Unternehmen | Position | Beginn |
|---|---|---|
Curavit Clinical Research Corp.
 Curavit Clinical Research Corp. BiotechnologyHealth Technology Engages in design and execute clinical trials | Gründer | 01.01.2020 |
Eden Capital Management LLC
 Eden Capital Management LLC Investment ManagersFinance Eden Capital Management invests in middle market companies located in the United States, Canada and Western Europe with an EBITDA of USD 3 - 5 million and an enterprise value of USD 150 million. The firm targets companies operating in the fields of technology, business services, and education sectors. It participates in growth and buyout capital transactions. The firm acquires majority and minority interest. | Private Equity Investor | - |
Ausbildung von Dave Hanaman
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
23
Beziehungen ersten Grades
3
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
University of California, Berkeley
 University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Eden Capital Management LLC
Eden Capital Management LLC Investment ManagersFinance Eden Capital Management invests in middle market companies located in the United States, Canada and Western Europe with an EBITDA of USD 3 - 5 million and an enterprise value of USD 150 million. The firm targets companies operating in the fields of technology, business services, and education sectors. It participates in growth and buyout capital transactions. The firm acquires majority and minority interest. | Finance |
Curavit Clinical Research Corp.
Curavit Clinical Research Corp. BiotechnologyHealth Technology Engages in design and execute clinical trials | Health Technology |
